Cancer CareApril 7, 2022
Annual Spotlight on Early Career Investigators to be held April 28, 2022
(SACRAMENTO)
Save the date for the 16th annual Spotlight on Early Career Investigators: A Cancer Research Mini-Symposium April 28, 2022. The annual event highlights cancer-related research being conducted by students, including post-doctoral students, research residents, and fellows in research.
This year’s event is back in person at UC Davis Comprehensive Cancer Center’s Goodnight Auditorium, from 1:30 p.m. to 5:00 p.m. Please click here to register.
The Spotlight gives early-stage investigators a chance to meet experienced investigators, learn about potential research opportunities early in their career, and gain valuable career insights through presentations and networking.
“Events like these provide our junior colleagues and scholars with much-needed opportunities to hone their presentation and networking skills,” said UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr. “The event also allows for connection to faculty, which is why faculty attendance is critical.”
This year, six early-stage investigators will be selected as symposium presenters, with others offering poster presentations. Criteria used to judge the applications include scientific innovation, significance, and ultimate potential for clinical impact. To submit abstracts for poster and oral presentations, please click on the registration site.
Shehnaz Hussain, associate director for population sciences at UC Davis Comprehensive Cancer, will provide the keynote address, which is titled “My Path in Cancer Epidemiology Forged by Mentorship, Opportunity, and Serendipity.
Hussain will discuss her research focused on the intersection of infections and cancer. She plans to contextualize how her research and career trajectory have been influenced by supportive mentors, seizing unusual or unexpected opportunities, and sometimes just being the right person at the right place at the right time.
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. For more information, visit cancer.ucdavis.edu.
